Ligand Pharmaceuticals | LGND - Cost Of Sales

Stock Price
190.44
Daily Change
-1.25 -0.65%
Monthly
-4.76%
Yearly
65.33%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $11.9M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Amgen USD 1.79B 128M Dec/2025
Baxter International USD 1.88B 66M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Gilead Sciences USD 1.57B 68M Sep/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Glaxosmithkline GBP 3.01B 853.01M Sep/2025
Insmed USD 30.9M 1.56M Sep/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
Ligand Pharmaceuticals USD 11.9M 733K Sep/2025
MacroGenics USD 44.3M 5.4M Sep/2025
Merck USD 3.32B 531M Dec/2025
Pacira USD 48.6M 6.59M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Veracyte USD 41.21M 196K Sep/2025